Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small-cell lung cancer Meeting Abstract


Authors: Gautschi, O.; Goto, K.; Oxnard, G.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T.; Gainor, J.; McCoach, C.; Besse, B.; Cho, B. C.; Peled, N.; Weiss, J.; Kim, Y. J.; Ohe, Y.; Horiike, A.; Park, K.; Huang, X.; Olek, E.; Subbiah, V.; Drilon, A.
Abstract Title: Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small-cell lung cancer
Meeting Title: 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 4
Meeting Dates: 2020 Oct 9-11
Meeting Location: Virtual
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-10-01
Start Page: 149
End Page: 150
Language: English
ACCESSION: WOS:000575955000339
PROVIDER: wos
DOI: 10.1159/000510995
Notes: Meeting Abstract: 87 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon